Clinical trial
Phase I, Randomized, Parallel Group Study to Evaluate the Effect of Multiple Oral Doses of Eurartesim on the QT/QTc Interval Compared to Riamet, Placebo and Moxifloxacin in Healthy Male and Female Volunteers
NCT01103830 is registered in ClinicalTrials.gov with sigma-tau i.f.r. S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I, Randomized, Parallel Group Study to Evaluate the Effect of Multiple Oral Doses of Eurartesim on the QT/QTc Interval Compared to Riamet, Placebo and Moxifloxacin in Healthy Male and Female Volunteers
- Lead sponsor
- sigma-tau i.f.r. S.p.A.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- December 31, 2010
- Enrollment
- 287 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.